Market Place
Sourcing Support
Roche’s Bispecific-ADC Combo keeps Lymphoma at Bay
24 Jun 2025 //
FIERCE PHARMA
AbbVie says blood cancer drug fails late-stage trial
16 Jun 2025 //
REUTERS
Roche Advances Prasinezumab to Ph3 in Parkinson’s Disease
16 Jun 2025 //
GLOBENEWSWIRE
Roche Shares Elevidys Safety Update in Non-Amb DMD Patients
15 Jun 2025 //
GLOBENEWSWIRE
Roche`s Tecentriq Reduces Recurrence, Deaths for Colon Cancer
07 Jun 2025 //
REUTERS
Roche`s Evrysdi tablet approved in EU
06 Jun 2025 //
PRESS RELEASE
Roche`s Evrysdi tablet approved by European Commission for SMA
04 Jun 2025 //
GLOBENEWSWIRE
Vividion secures clinical-stage WRN inhibitor from Roche
04 Jun 2025 //
FIERCE BIOTECH
Roche & Jazz Link Drug Combo to Improve Survival in Ph 3 Trial
04 Jun 2025 //
BIOSPACE
Roche`s Itovebi Extends Survival in HR-Positive Breast Cancer
31 May 2025 //
GLOBENEWSWIRE
Roche links BTK drug to low relapse rate across 96-week MS trial
30 May 2025 //
FIERCE BIOTECH
Roche`s Fenebrutinib Shows 2-Year Benefit in Relapsing Sclerosis
29 May 2025 //
GLOBENEWSWIRE
Roche moves antibiotic against superbug into Phase 3 of testing
27 May 2025 //
REUTERS
Roche’s Columvi Shows 2-Year OS In Relapsed DLBCL Patients
23 May 2025 //
GLOBENEWSWIRE
Roche And Broad Labs Partner On SBX Sequencing Adoption
23 May 2025 //
GLOBENEWSWIRE
Roche Taps Broad Institute to Test Sbx Sequencing in The Clinic
23 May 2025 //
FIERCE BIOTECH
CHMP recommends EU approval of Roche`s Itovebi for breast cancer
23 May 2025 //
GLOBENEWSWIRE
Genentech`s Columvi Extends Survival in Lymphoma Patients
23 May 2025 //
BUSINESSWIRE
ASCO: Roche highlights Itovebi`s Breast Cancer Survival Win
22 May 2025 //
FIERCE PHARMA
ASCO: Roche, Jazz Lung Cancer Win Leaves Room for Improvement
22 May 2025 //
FIERCE PHARMA
FDA Approves Genentech`s Susvimo for Diabetic Retinopathy
22 May 2025 //
BUSINESSWIRE
Genentech Bets Again on Orionis With $2B+ in Glue Space
22 May 2025 //
BIOSPACE
Genentech Update on FDA Meeting for Columvi in Lymphoma
20 May 2025 //
BUSINESSWIRE
J&J, Pfizer and Roche face FDA questions over data applicability
17 May 2025 //
FIERCE PHARMA
Roche questions US investment plans after Trump executive order
15 May 2025 //
FIERCE PHARMA
Roche’s MET RxDx Assay Approved by FDA for Emrelis Use in NSCLC
14 May 2025 //
GLOBENEWSWIRE
Genentech honors hemophilia A caregivers in Hemlibra short film
14 May 2025 //
FIERCE PHARMA
Roche boosts US presence with new $700M North Carolina facility
13 May 2025 //
REUTERS
Roche invests $550 million to expand Indianapolis hub
12 May 2025 //
PR NEWSWIRE
Roche puts up nearly $300M to expand manufacturing in China
10 May 2025 //
FIERCE PHARMA
Zealand Pharma closes deal with Roche
09 May 2025 //
GLOBENEWSWIRE
Roche Launches Elecsys PRO-C3 Test for Liver Fibrosis
06 May 2025 //
GLOBENEWSWIRE
CHMP recommends label update for Roche`s Phesgo
30 Apr 2025 //
GLOBENEWSWIRE
Roche nets FDA breakthrough label for AI lung cancer CDx test
29 Apr 2025 //
FIERCE BIOTECH
Roche profits 100 times more on Indian medicine, defends move
28 Apr 2025 //
ECONOMICTIMES
Tariffs make M&A decisions `more difficult,` says Roche CEO
24 Apr 2025 //
FIERCE BIOTECH
Roche works to mitigate US tariff impact with exemption
24 Apr 2025 //
FIERCE PHARMA
Roche reports 6% sales growth in Q1 2025
24 Apr 2025 //
GLOBENEWSWIRE
Roche gets CE Mark for Chest Pain Triage algorithm to detect of ACS
23 Apr 2025 //
GLOBENEWSWIRE
Roche to invest $50 billion in US over next five years
22 Apr 2025 //
REUTERS
Roche discontinues low dose in Huntington’s trial
19 Apr 2025 //
ENDPTS
Oak Hill Bio Licenses Angelman Syndrome Treatment to Roche
15 Apr 2025 //
BUSINESSWIRE
EU Commission OKs Roche`s Columvi as first bispecific antibody
14 Apr 2025 //
GLOBENEWSWIRE
Inka Health Publishes Roche-Sponsored Study on Oncology Research
10 Apr 2025 //
ACCESSWIRE
Roche`s Brainshuttle tech promises next-gen amyloid beta mAbs
08 Apr 2025 //
EXPRESSPHARMA
NATCO Pharma updates on legal proceedings for Risdiplam launch
08 Apr 2025 //
INDPHARMAPOST
Roche unveils Alzheimer`s advancements at AD/PD 2025
03 Apr 2025 //
GLOBENEWSWIRE
Genentech and Roche reveal Alzheimer`s advancements at AD/PD 2025
03 Apr 2025 //
BUSINESSWIRE
Roche`s high-dose version of Ocrevus flunks phase 3 trial
03 Apr 2025 //
FIERCE PHARMA
Roche Annual General Meeting 2025
25 Mar 2025 //
GLOBENEWSWIRE
Novartis & Roche ditch some diversity programmes on US concerns
20 Mar 2025 //
REUTERS
Roche doubles down on ADCs in $1B biobucks pact with Oxford Bio
19 Mar 2025 //
FIERCE BIOTECH
Roche to share neuromuscular advancements at MDA 2025 conference
17 Mar 2025 //
GLOBENEWSWIRE
Roche settles UPenn patent lawsuit over breast cancer drugs
17 Mar 2025 //
FIERCE PHARMA
Roche pairs with Zealand Pharma on obesity drug candidate
12 Mar 2025 //
REUTERS
$2.4B gene therapy impairment sparks Roche restructure
11 Mar 2025 //
FIERCE PHRMA
Roche Launches Genentech Innovation Center In Boston
07 Mar 2025 //
GLOBENEWSWIRE
FDA Accepts sBLA For Genentech’s Gazyva In Lupus Nephritis
06 Mar 2025 //
BUSINESSWIRE
Roche/BioNTech vaccine shows early promise in pancreatic cancer
06 Mar 2025 //
REUTERS
Roche’s Xolair Doubles Success Rate In Food Allergy Trial
03 Mar 2025 //
BUSINESSWIRE
